Johnson & Johnson (JNJ) Tops Q4 EPS by 11c, Revenues Misses; Guides EPS Above Views
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $262.37 +0.78%
Financial Fact:
Cost of products sold: 5.49B
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Cost of products sold: 5.49B
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.35, $0.11 better than the analyst estimate of $2.24. Revenue for the quarter came in at $23.7 billion versus the consensus estimate of $23.9 billion.
GUIDANCE:
Johnson & Johnson sees FY2023 EPS of $10.50, versus the consensus of $10.33.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
